InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,459.10
(
1.11%
)
US TECH 100
18,514.00
(
1.00%
)
Dow Jones
40,589.34
(
1.64%
)
Brent Oil
79.75
(
0.00%
)
Bitcoin
68,057.63
(
0.38%
)
Post# of 252713
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 120144
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 107731

Monday, 11/01/2010 5:32:48 PM

Monday, November 01, 2010 5:32:48 PM

Post# of 252713

MNTA/NVS/TEVA/MYL—In general, what is the good, bad and ugly regarding the Courts combining the Mylan and Sandoz lawsuits?

It’s a minor negative for MNTA insofar as it delays the start of the Copaxone trial by a few months. In other respects, the decision is essentially neutral for MNTA.

Note that SNY’s Lovenox suits against Teva and Amphastar started out as separate cases and were consolidated by the District Court. This is a common practice in Hatch-Waxman patent cases.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up